Allarity Therapeutics, Inc. ALLR
1.03
(0.06)
(5.50%)
as of 25 Sep
- Market cap
- $17.3M
- P/E
- 0.0×
Follow ALLR
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | 0.00 |
P/S ratio |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | 0.00 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | 0.00 |
P/Operating CF |
(18,313,192.29) | (18,313,192.29) | (18,313,192.29) | (18,313,192.29) | — | — | — | — | — | (4.79) |
P/B ratio |
2,305,433.40 | 2,305,433.40 | 2,305,433.40 | 2,305,433.40 | — | — | — | — | — | 1.58 |
Price to Tangible BV |
74,570,839.69 | 74,570,839.69 | 74,570,839.69 | 74,570,839.69 | — | — | — | — | — | 57.30 |
EV/Sales |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | 0.00 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | 0.00 |
EV/Operating CF |
(5,257,685.33) | (5,257,685.33) | (5,257,685.33) | (5,257,685.33) | — | — | — | — | — | (0.23) |
EV/FCF |
(5,257,685.33) | (5,257,685.33) | (5,257,685.33) | (5,257,685.33) | — | — | — | — | — | (0.23) |
Quick Ratio |
2.58 | 0.67 | 0.35 | 0.67 | 0.22 | 1.00 | 0.25 | 0.07 | 2.00 | 1.85 |
Current Ratio |
2.71 | 0.77 | 0.41 | 0.71 | 0.31 | 1.03 | 0.44 | 0.14 | 2.06 | 2.13 |
Net Debt/EBITDA |
0.36 | 0.12 | (0.44) | 0.06 | (0.23) | 0.72 | (0.10) | (0.07) | 1.04 | 1.05 |
Debt/Assets |
0.00% | 0.00% | 7.51% | 3.05% | 6.61% | 1.99% | 25.63% | 10.96% | 5.96% | 7.67% |
Debt/Equity |
0.00 | 0.00 | 0.12 | 0.05 | 0.09 | 0.05 | (32.98) | (0.47) | 0.11 | 0.14 |
Asset Turnover |
0.28 | 0.70 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 |
Operating CF/Net income |
0.74 | 0.27 | 1.85 | 0.71 | 1.10 | 0.56 | 0.80 | 0.62 | 0.69 | 1.32 |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | (0.07) | 0.00 | 0.00 | 0.00 | (0.03) | 0.62 |
Interest Coverage |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (158.64%) | (479.08%) | (19.21%) | (12.09%) | (50.05%) | (125.13%) | (233.39%) | 886.50% | (687.46%) | (103.80%) | |
| (71.91%) | (412.00%) | (12.05%) | (7.41%) | (35.88%) | (64.18%) | (65.60%) | (154.63%) | (145.77%) | (54.91%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | (19.73%) | 0.00% | (1,358.95%) | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(126.29%) | 1,294.46% | 73.38% | 1,524.28% | 173.87% | (3,845.31%) | 337.73% | 167.67% | (212.97%) | (114.28%) |
Average Days of Receivables |
637.21 | 269.60 | 1,806.64 | 5,037.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 987.78 |
Research and Development Expense of Revenue |
321.30% | 309.84% | 1,834.89% | 5,305.83% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2,062.81% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | (1,834.89%) | 3,154.17% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1,976.25% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.94 | 0.88 | 0.91 | 0.57 | 0.66 | 0.83 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 213.13% |
Graham Net Nets |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | 0.61 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | 0.00 |
Earnings Yield |
0.00% | 0.00% | 0.00% | 0.00% | — | — | — | — | — | (74.07%) |
Free Cash Flow Yield |
0.00% | 0.00% | 0.00% | 0.00% | — | — | — | — | — | (97.54%) |
Revenue per Share |
1.05 | 1.34 | 0.39 | 0.28 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 |
Operating CF per Share |
(2.01) | (2.17) | (4.96) | (24.00) | (2.22) | (2.34) | 0.00 | (3,748.53) | (10.80) | (1.03) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (0.19) | 0.00 |
Free Cash Flow per Share |
(2.01) | (2.17) | (4.96) | (24.00) | (2.22) | (2.34) | 0.00 | (3,748.53) | (10.98) | (1.03) |
Cash per Share |
1.33 | 0.88 | 0.27 | 3.62 | 0.09 | 3.13 | 0.00 | 48.82 | 12.15 | 1.02 |
Shareholders Equity per Share |
2.74 | 0.65 | 27.46 | 42.93 | 7.49 | 2.85 | 0.00 | (809.12) | 7.35 | 0.68 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
2.74 | 0.65 | 27.46 | 42.93 | 7.49 | 2.85 | 0.00 | (809.12) | 7.35 | 0.68 |
Free Cash Flow |
(1.18) | (1.32) | (4.25) | (1.09) | (7.25) | (14.89) | (16.83) | (12.74) | (17.65) | (14.83) |
Working Capital |
1.23 | (0.39) | (3.18) | (0.15) | (3.82) | 0.69 | (6.25) | (12.20) | 11.50 | 9.50 |
Capital Expenditures |
(0.01) | — | (0.13) | 0.00 | 0.00 | — | (0.02) | — | (0.30) | (0.01) |
Net Current Asset Value |
1.23 | (0.39) | (8.37) | (0.79) | (7.25) | (10.08) | (9.69) | (12.64) | 11.50 | 9.50 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — | 0.00 | 0.03 |
Net Profit Margin |
(257.94%) | (590.67%) | (695.81%) | (11,927.50%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (3,509.69%) |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.23 | 0.39 | 0.59 | 0.19 | 2.19 | 13.25 | 839.57 | 1.85 | 31.43 | (0.04) |
Cash ROIC |
(50.55%) | (144.19%) | (16.16%) | (51.28%) | (26.99%) | (38.14%) | (298.39%) | 993.39% | (54.02%) | (58.46%) |
Accounts Receivable Turnover |
0.74 | 0.97 | 0.30 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.21 |
Accounts Payable Turnover |
2.56 | 8.39 | 5.51 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
6.20 | 20.36 | 0.00 | — | 0.00 | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
104.70 | 55.07 | 109.37 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
42.22 | 22.99 | 0.00 | — | 0.00 | 0.00 | 0.00 | — | — | — |
Average Receivables |
0.84 | 0.84 | 1.12 | 0.91 | 0.54 | 0.87 | 0.81 | 0.80 | 1.50 | 1.53 |
Average Payables |
0.32 | 0.32 | 1.16 | 2.06 | 2.16 | 1.41 | 3.47 | 7.33 | 6.30 | 4.23 |
Average Inventory |
0.13 | 0.13 | — | — | — | — | — | — | — | — |
Average Assets |
2.21 | 1.16 | 19.06 | 20.76 | 18.40 | 41.52 | 32.09 | 13.20 | 17.26 | 20.45 |
Average Common Equity |
1.00 | 1.00 | 11.96 | 12.73 | 13.19 | 21.30 | 9.02 | (2.30) | 3.66 | 10.82 |
Columns are period end dates